Navigation Links
A Drop of Blood May Help Assess Cancer Therapy
Date:4/13/2009

Technique could one day quickly detect if treatment is working, study suggests

MONDAY, April 13 (HealthDay News) -- A specialized technique that can detect subtle changes in cancer cells contained in a drop of blood or a tiny piece of tissue may one day be used by doctors to better assess how cancers are responding to treatment, say U.S. researchers.

"Currently, we don't know what's going on in a patient's actual tumor cells when a treatment is given. The standard way we measure if a treatment is working is to wait several weeks to see if the tumor mass shrinks. It would really be a leap forward if we could detect what is happening at the cellular level," lead author Dr. Alice Fan, a clinical instructor in the oncology division at the Stanford University School of Medicine in California, said in a school news release.

"This technology allows us to analyze cancer-associated proteins on a very small scale," senior study author Dr. Dean Felsher, an associate professor of medicine and of pathology, said in the news release. "Not only can we detect picogram levels -- one-trillionth of a gram -- of protein, but we can also see very subtle changes in the ways the protein is modified."

Variations in the way a protein is modified can affect how it functions in tumor progression. Cancer cells can dodge common therapies by changing their levels of protein expression and degrees of modification, according to background information in the news release.

The ability to continuously analyze small samples from cancer patients undergoing treatment may help doctors identify "rogue" cells before they can create a more treatment-resistant tumor. This technology could also help identify patients with cancers that are resistant to standard treatments.

Tests showed the technique was effective in samples of blood cancers, and the researchers hope it will also help track solid tumors. The Stanford team collaborated with researchers from Cell Biosciences, which makes the machine used in the study.

The study is in the April 12 online issue of the journal Nature Medicine.

More information

The U.S. National Cancer Institute has more information about cancer.



-- Robert Preidt



SOURCE: Stanford University, news release, April 12, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cord Blood America Announces First Storage Sale in Germany; Commitment to Expansion
2. Blood tests reveal tobacco smoke residues in non-smoking New Yorkers
3. Growth factor TGF-B helps maintain health of retinal blood vessels
4. Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center
5. CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents
6. More U.S. Kids Taking Diabetes, Blood Pressure Drugs
7. Stem cell therapy grows new blood vessels
8. Cord Blood Announces $1.75 Million Reduction in Long Term Debt
9. Arthritis Trial Leads to Potential Cure for High Blood Pressure
10. World-first high blood pressure treatment trialled in Melbourne
11. Haemonetics Bolsters Blood Bank Information Management Portfolio With Acquisition of Altivation Software
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A Drop of Blood May Help Assess Cancer Therapy
(Date:4/29/2016)... York, NY (PRWEB) , ... April 29, 2016 , ... New York City based oral ... . This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in the ... of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... Calif. , April 28, 2016 /PRNewswire/ ... Validation Lifecycle Management Solutions (VLMS) today announced ... and services for sufferers of chronic kidney ... System to manage their corporate validation process. ... seeking a software solution to manage their ...
Breaking Medicine Technology: